Crossmark

Plasma levels of soluble podoplanin are higher in acute promyelocytic leukemia compared to other forms of acute myeloid leukemia

Crossref DOI link: https://doi.org/10.1016/j.htct.2025.106227

Published Print: 2026-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Moraes, Carla Roberta Peachazepi https://orcid.org/0000-0002-6871-7097
Saraiva, Camilla Maria de Alencar

Borba-Junior, Ivanio Teixeira

Duarte, Bruno Kosa Lino https://orcid.org/0000-0002-6155-3253
de Campos, Paula Melo

Saad, Sara Teresinha Olalla https://orcid.org/0000-0003-0809-8068
De Paula, Erich Vinicius https://orcid.org/0000-0003-1539-7912
Funding

Funding for this research was provided by:

State University of Campinas Teaching Research and Extension Support Fund

Fundação de Amparo à Pesquisa do Estado de São Paulo (2022/13216\u20130)

Fundação de Amparo à Pesquisa do Estado de São Paulo (2023/03765\u20130)

Fundação de Amparo à Pesquisa do Estado de São Paulo (2633/23)

Coordination for the improvement of Higher Education Personnel
License Information

Text and Data Mining valid from 2026-01-01

Text and Data Mining valid from 2026-01-01

Version of Record valid from 2025-11-15
More Information

This article is maintained by: Elsevier

Article Title: Plasma levels of soluble podoplanin are higher in acute promyelocytic leukemia compared to other forms of acute myeloid leukemia

Journal Title: Hematology, Transfusion and Cell Therapy

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.htct.2025.106227

Content Type: article

Copyright: © 2025 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier España, S.L.U.